Q1 2025 Holdings
Filed 2025-05-15 | 75 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $113.5M | 1,400,000 | 8.2% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $112.2M | 2,846,703 | 8.1% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $98.4M | 5,521,414 | 7.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $79.6M | 441,758 | 5.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $76.3M | 1,079,304 | 5.5% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $53.9M | 12,478,351 | 3.9% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $50.4M | 7,089,822 | 3.6% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $47.9M | 155,394 | 3.4% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $45.2M | 2,562,893 | 3.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $43.2M | 1,139,740 | 3.1% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $41.6M | 3,395,341 | 3.0% |
| Neuropace Inc(NPCE) | COM | 641288105 | $32.1M | 2,608,168 | 2.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $28.8M | 2,422,833 | 2.1% |
| Axogen Inc(AXGN) | COM | 05463X106 | $26.8M | 1,446,117 | 1.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $26.0M | 2,574,122 | 1.9% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $25.9M | 7,785,000 | 1.9% |
| Surmodics Inc(SU6) | COM | 868873100 | $24.1M | 789,060 | 1.7% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $23.6M | 1,072,204 | 1.7% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $22.5M | 8,167,100 | 1.6% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $22.4M | 67,500 | 1.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $20.9M | 274,272 | 1.5% |
| Rigel Pharmaceuticals Inc(RIGL) | COM | 766559702 | $20.3M | 1,130,679 | 1.5% |
| Hologic Inc(HOLX) | COM | 436440101 | $18.7M | 302,000 | 1.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $17.1M | 28,940 | 1.2% |
| Merus N V | COM | N5749R100 | $16.2M | 385,821 | 1.2% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $15.2M | 214,357 | 1.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $15.0M | 224,684 | 1.1% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $14.3M | 7,309,254 | 1.0% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $13.9M | 6,325,000 | 1.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $13.0M | 1,079,158 | 0.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $12.8M | 814,652 | 0.9% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $12.5M | 226,218 | 0.9% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $11.2M | 6,978,942 | 0.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $10.7M | 150,000 | 0.8% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $10.4M | 469,500 | 0.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $10.0M | 153,031 | 0.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.0M | 816,610 | 0.7% |
| Orthofix MED Inc(OFIX) | COM | 68752M108 | $9.8M | 601,925 | 0.7% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $9.5M | 496,039 | 0.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $9.2M | 285,000 | 0.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $8.8M | 56,300 | 0.6% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $8.2M | 169,000 | 0.6% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $7.9M | 7,293,007 | 0.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $7.4M | 303,585 | 0.5% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $6.9M | 450,500 | 0.5% |
| Theratechnologies Inc(TQ80) | COM NEW | 88338H704 | $6.7M | 4,801,376 | 0.5% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $6.4M | 1,494,420 | 0.5% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $6.2M | 39,000 | 0.4% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $5.6M | 935,909 | 0.4% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $4.7M | 117,000 | 0.3% |